Multiple Sclerosis Studied With PEMF Pulsed ElectroMagnetic Fields Therapy
This article reports on the case of a 55-year-old female chronic progressive multiple sclerosis patient who received a single external application of low magnetic fields (7.5-picotesla; 5-Hz frequency), which lasted 20 minutes. The treatment quickly led to improvements in a variety of areas, including fatigue, sleep, vision, bladder function, movement and speech problems, and mood.
R. Sandyk, “Rapid Normalization of Visual Evoked Potentials picoTesla Range Magnetic Fields in Chronic Progressive Multiple Sclerosis,” International Journal of Neurosci, 77(3-4), August 1994, p. 243-259.
This study reports on four cases of multiple sclerosis that experienced improvements in visuospatial and visuomotor functions following treatment with external application of low magnetic fields.
R. Sandyk, “Further Observations on the Effects of External picoTesla Range Magnetic Fields on Visual
Memory and Visuospatial Functions in Multiple Sclerosis,” International Journal of Neurosc, 77(3-4), August 1994, 203-27
This article reports on the case of a 50-year-old female chronic progressive multiple sclerosis patient who received a single external application of low magnetic fields who experienced significant improvements following the treatment.
R. Sandyk, “Successful Treatment of Multiple Sclerosis with Magnetic Fields,” International Journal Neurosci, 66(3-4), October 1992, p. 237-250.
This article reports on the cases of three patients suffering from long-time symptoms of multiple sclerosis who received treatment with extra cerebral pulsed electromagnetic fields over a period of between 6 and 18 months. Results showed all three patients experienced significant improvements in cognitive functions.
R. Sandyk, “Progressive Cognitive Improvement in Multiple Sclerosis from Treatment with Electromagnetic Fields,” International Journal of Neurosci, 89(1- January 1997, p. 39-51.
This is a report on the cases of two chronic multiple sclerosis patients exhibiting severe speech problems. Symptoms were completely resolved following 3-4 weeks of treatment with pulsed electromagnetic fields.
R. Sandyk, “Resolution of Dysarthria in Multiple Sclerosis Treatment with Weak Electromagnetic Fields,” International Journal of Neurosci, 83(1-2), November 1995, p. 81-92.
The cases of three female multiple sclerosis patients exhibiting suicidal behavior are discussed in this article. Treatment with pulsed pico tesla-level electromagnetic fields resolved the suicidal behavior in all three patients, an improvement that was maintained over a follow-up period of 3.5 years.
R. Sandyk, “Suicidal Behavior is Attenuated in Patients with Multiple Sclerosis Treatment with Electromagnetic Fields,” International Journal of Neurosci, 87(1- 2), October 1996, p. 5-15.
This article reports on the cases of two multiple sclerosis patients suffering from chronic ataxia who performed poorly on human figure drawing tests administered to measure body image perception.
Treatment with extra cerebral applications of picotesla flux electromagnetic fields led to improvements in gait and balance as well as normalization in body image perception as seen on a repeat of the same test each patient.
R. Sandyk, “Effect of Weak Electromagnetic Fields on Body Image Perception in Patients with Multiple
Sclerosis, ” International Journal of Neurosci, 86(1-2), July 1996, p. 79-85.
This article reports on the cases of three multiple sclerosis patients suffering from a chronic progressive course of the disease who experienced a reduction in tremors following treatment with brief external applications of pulsed EMFs of 7.5-pT intensity.
R. Sandyk & L.C. Dann, “Weak Electromagnetic Fields Attenuate Tremor in Multiple Sclerosis,” International Journal of Neurosci, 79(3-4), December 1994, p. 199-212.
This article reports on the cases of three female multiple sclerosis patients with poor word fluency who experienced a 100-percent increase in word output following 4-5 sessions of treatment with external applications of extremely weak electromagnetic fields in the pico tesla range of intensity.
R. Sandyk, Improvement in Word-fluency Performance in Patients with Multiple Sclerosis Electromagnetic Fields,” International Journal Neurosci, 79(1-2), November 1994, p.75-90.
This article reports on the cases of three multiple sclerosis patients experiencing continuous and debilitating daily fatigue over the course of several years. Treatment with extracranially applied picotesla flux electromagnetic fields dramatically improved symptoms of fatigue in all three patients.
R. Sandyk, Treatment with Weak Electromagnetic Fields Improves Fatigue Associated with Multiple Sclerosis, International Journal of Neurosci, 84(1-4), February 1996, p. 177-186.
Results of this double blind, placebo-controlled study found that pulsed electromagnetic fields administered daily over a period of 15 days proved to be an effective treatment in reducing spasticity and incontinence associated with multiple sclerosis.
A. Guseo, Double-Blind Treatments with Pulsating Electromagnetic Field in Multiple Sclerosis, Hungarian Symposium on Magneto therapy, 2nd Symposium, May 16-17, 1987, Szekesfehervar, Hungary, p. 85-89.
Results of this double-blind, placebo-controlled study indicated that pulsed electromagnetic fields administered daily over a period of 15 days is a generally effective treatment in reducing symptoms
associated with multiple sclerosis, with the most positive improvements involving the alleviation of
spasticity and pain.
A. Guseo, Pulsing Electromagnetic Field Therapy of Multiple Sclerosis the Gyuling-Bordacs Device: Double Blind, Crossover and Open Studies, Journal of Bioelectr., 6(1), 1987, p. 23-35.
Results of this double blind, placebo-controlled study indicated that exposure to magnetic fields produced beneficial clinical effects in patients suffering from cerebral paralysis and in patients with
multiple sclerosis.
A. Sieron, The Variable Magnetic Fields in the Complex Treatment of Neurological Diseases, European
Bioelectromagnetics Association, 3rd International Congress, 29 February – 3 March 1996, Nancy, France.
